The Effectiveness of the Android Application as a Pharmaceutical Education Tool in Hypertensive Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-16

Study Completion Date

2023-06-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypertension is a worldwide public health challenge due to its high prevalence and along with increased risk of complications of other diseases that are more dangerous if not managed properly. An estimated 1.4 billion people worldwide have high blood pressure, but only 14% can control it. Knowledge of hypertension in patients with hypertension can prevent complications through hypertension treatment. Increasing knowledge can be done by providing education in the form of counseling by pharmacists to hypertensive patients. Counseling activities carried out by pharmacists can be supported by a technological approach. One of the uses in smartphone technology is by creating an android-based mobile application that can be developed to support pharmaceutical care. Education conducted by pharmacists can increase knowledge that will affect hypertension treatment adherence, and this education can also improve blood pressure control so that it can improve the quality of life. The purpose of this study is to analyze the influence of the android application as a standard pharmacist education tool on knowledge as well as adherence and therapeutic outcomes of hypertensive patients, and quality of life related to the health of hypertensive patients compared to just providing standard education by pharmacists to hypertensive patients at the Primary Health Care. The method used in this study is a Quasi-Experimental with Pretest - Posttest Control Group Design. Samples were obtained by purposive sampling method at the selected Primary Health Care as the intervention group and the selected Primary Health Care as the control group. Pharmacist provides education to intervention groups with android applications as counseling aids and in control groups only standard counseling is provided. Pre-test data collection was done by taking primary and secondary data of patients at the first meeting and post-test data collection was taken prospectively through face-to-face interviews and questionnaires on hypertensive patients participants for three months by observing the influence of android applications as counseling aids on knowledge of hypertensive diseases, adherence to antihypertensive treatment, outcome therapy and quality of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Targeted and Tailored Pharmacist Intervention to Improve Adherence to Antihypertensive Drugs Among Diabetes Patients

NCT04023734

Diabetes Mellitus, Type 2 Hypertension Medication Nonadherence

COMPLETED NA

Improving Medication Use in Patients With Hypertension

NCT00388817

Hypertension

COMPLETED NA

Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients

NCT06558877

Hypertension

RECRUITING NA

Educational Intervention in Pharmacovigilance for Hospital Health Professionals

NCT02134587

Adverse Drug Reaction

COMPLETED NA

Impact of Clinical Pharmacist-Led Intervention on Management of Diabetic Hypertensive Patients in Eastern Nepal

NCT05707481

Type 2 Diabetes Hypertension

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Pharmacy Education with Android Application as a Tool Conducted for Three Months in Hypertensive Patients to Improve Knowledge, Adherence, Outcome Therapy and Quality of Life

Group Type EXPERIMENTAL

Android Application

Intervention Type DEVICE

Android Application for 3 months

Pharmacy education

Intervention Type BEHAVIORAL

Pharmacy education in hypertensive patients

Pharmacy education

Pharmacy education in hypertensive patients

Group Type ACTIVE_COMPARATOR

Pharmacy education

Intervention Type BEHAVIORAL

Pharmacy education in hypertensive patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Android Application

Android Application for 3 months

Intervention Type DEVICE

Pharmacy education

Pharmacy education in hypertensive patients

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged ≥ 18 years, male and female who are willing to be respondents.
* Patients diagnosed with hypertension or currently taking ≥ 1 antihypertensive drug.
* Hypertension patients who carry out routine control and receive anti-hypertensive drugs for at least 3 months at the Health Center.
* Not illiterate and owns a smartphone.
* Patients who are willing to participate in the study by signing an informed consent.

Exclusion Criteria

* Physical and mental disabilities such as deaf, blind, and psychiatric disorders.
* The patient is pregnant
* Currently taking hormonal drugs and other routine drugs such as TB, HIV and AIDS drugs.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No